Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.
about
Highlights on distinctive structural and functional properties of HTLV Tax proteinsMolecular Mechanisms of HTLV-1 Cell-to-Cell TransmissionFrom Immunodeficiency to Humanization: The Contribution of Mouse Models to Explore HTLV-1 LeukemogenesisHow does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?The Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesisModes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and PersistenceMechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virusImmunopathogenesis and neurological manifestations associated to HTLV-1 infectionIdentification of diverse full-length endogenous betaretroviruses in megabats and microbatsT-cell lymphomas, a challenging disease: types, treatments, and future.RNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.Differential role of PKC-induced c-Jun in HTLV-1 LTR activation by 12-O-tetradecanoylphorbol-13-acetate in different human T-cell lines.HTLV-1-associated adult T cell leukemia is highly susceptible to Navitoclax due to enhanced Bax expression.Newly emerging therapies targeting viral-related lymphomas.The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma.Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein.The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties.Angiotensin II type 1 receptor blocker telmisartan induces apoptosis and autophagy in adult T-cell leukemia cells.Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infectionMassive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection.pecific nutrient combination effects on tax, NF- κB and MMP-9 in human T-cell lymphotropic virus -1 positive malignant T-lymphocytes.Clonality of HTLV-2 in natural infection.MicroRNAs and human retrovirusesMolecular determinants of human T-lymphotropic virus type 1 transmission and spread.Ubiquitin-independent proteasomal degradation during oncogenic viral infections.Role of O-glycosylation and expression of CD43 and CD45 on the surfaces of effector T cells in human T cell leukemia virus type 1 cell-to-cell infectionInducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma.Human T-cell leukemia virus type 1 (HTLV-1) latency: death signaling awakens the sleeping retrovirus.CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis.Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cellsCellular Factors Involved in HTLV-1 Entry and PathogenicitHuman T-cell leukemia virus type 1 (HTLV-1) bZIP factor requires cellular transcription factor JunD to upregulate HTLV-1 antisense transcription from the 3' long terminal repeat.The human T-lymphotropic virus type 1 tax protein inhibits nonsense-mediated mRNA decay by interacting with INT6/EIF3E and UPF1.Human T-cell leukemia virus type 2 antisense viral protein 2 is dispensable for in vitro immortalization but functions to repress early virus replication in vivo.Radiation therapy for the management of patients with HTLV-1-associated adult T-cell leukemia/lymphoma.HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory ReceptorsTumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy.Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell LeukemiaImpact of cellular autophagy on viruses: Insights from hepatitis B virus and human retroviruses.The discovery of HTLV-1, the first pathogenic human retrovirus.
P2860
Q21131117-97F0D410-9653-4F02-8B1D-6ECE9CC1FC00Q26752562-996F2383-2FC3-4B41-80F9-BCDDA8AB7661Q26774369-41883E2B-60BD-4999-B26C-A3F67ED5F988Q26785554-BE8BD851-6AD5-4E3F-B05E-CC17F59E066CQ26800055-9AEBC745-0E2F-46D6-B08D-A0F4AC17720AQ26801294-E3F664B6-6114-4CE8-9238-721DFD703D02Q26863681-C8A252CA-8BFD-40A6-B223-30F3E7131FA9Q27026230-E728364F-E1B0-4CB6-928A-3C2445A82C8CQ28709205-D7AB11E9-0DBF-4A8D-8120-6FB38E243537Q30244553-2ADFDEF5-3B00-4322-B95A-D19432AC6CBAQ30252424-47CC6D5C-5486-4E29-B219-FE6987AF5B7EQ31047557-9E056E4D-FCC9-4CE3-BAE8-09F7A952D6FFQ33425096-414B81EA-A302-4145-9BDD-37631A29782CQ33699201-741D9EF5-AED5-42A3-A505-6F7432D68E09Q33781166-1CCA1FC8-7DD0-4FA4-81FB-313B9FD749B7Q34070440-44AC46B0-5B69-461F-AF41-3B8AFA20B261Q34387588-F59D7B00-E320-40DD-B47A-346A8D39939DQ34534229-30C142A3-A489-496B-A983-A9E32C8C232FQ34649734-8773C203-03F7-4992-9B91-2C3F0E649437Q35008829-3BC4C3E2-4697-4E75-8DF4-505B4A759BFAQ35092998-DDC848AF-FAE2-46F6-AC30-AC7E98EE43C1Q35120139-8B42E618-AC7A-45EF-9E95-89AAE8008C5DQ35226238-B0CAB5E4-EEE5-4045-8290-325E1439917FQ35261463-4AF024C8-BB1D-4238-B029-E3CC2CDDD587Q35354212-FD741DEF-19FC-45D4-9E8C-BC9BB352232CQ35826108-A0D43DDD-DB84-45BE-92AB-2E794E2C05E3Q35945853-2818F7EB-F86B-4242-B186-445BB2BC69E8Q35974679-96843345-E088-47F4-8C16-4D0FB0D4AEB0Q35997030-851F3075-AF61-4273-BA36-69DA12B32D50Q36033266-EB7D8E8D-8CF5-4D27-84F3-E946E9AFE0D1Q36049779-ECDE4D2A-75DD-4324-8546-C68C6E5E0C79Q36154850-075B91BC-2240-490D-B9A5-3247B583B357Q36155451-0482233A-BA21-464E-9EBF-6135BF38A910Q36172168-76D85861-F961-454E-96D0-4EACECE7B34CQ36206416-683BA347-F7DE-423E-837C-42DC8F9084CEQ36238411-B0A74233-362A-45E8-BBBF-4CD2E220321EQ36270244-7AF045E1-64A6-4274-A280-859FD558E836Q36281149-0A6BA13A-2383-4074-8044-6C70E8C34436Q36389858-5C84EAEB-145F-4404-B907-40505B0505DAQ36419929-C982ADB5-AE84-4A64-B833-01ADF1A61220
P2860
Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Human T-cell leukemia virus ty ...... ctivity, Tax, HBZ and therapy.
@ast
Human T-cell leukemia virus ty ...... ctivity, Tax, HBZ and therapy.
@en
type
label
Human T-cell leukemia virus ty ...... ctivity, Tax, HBZ and therapy.
@ast
Human T-cell leukemia virus ty ...... ctivity, Tax, HBZ and therapy.
@en
prefLabel
Human T-cell leukemia virus ty ...... ctivity, Tax, HBZ and therapy.
@ast
Human T-cell leukemia virus ty ...... ctivity, Tax, HBZ and therapy.
@en
P2860
P356
P1433
P1476
Human T-cell leukemia virus ty ...... ctivity, Tax, HBZ and therapy.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2010.537
P407
P577
2010-11-29T00:00:00Z